The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia

dc.contributor.authorDiNardo, Courtney D.
dc.contributor.authorPratz, Keith W.
dc.contributor.authorPanayiotidis, Panayiotis
dc.contributor.authorWei, Xudong
dc.contributor.authorVorobyev, Vladimir
dc.contributor.authorIllés, Árpád
dc.contributor.authorKim, Inho
dc.contributor.authorIvanov, Vladimir
dc.contributor.authorKu, Grace
dc.contributor.authorMiller, Catherine
dc.contributor.authorZhang, Meng
dc.contributor.authorTatsch, Fernando
dc.contributor.authorPotluri, Jalaja
dc.contributor.authorSchmidt, Xenia
dc.contributor.authorRécher, Christian
dc.date.accessioned2025-02-21T08:32:38Z
dc.date.available2025-02-21T08:32:38Z
dc.date.issued2024
dc.date.oa2025-06-19
dc.date.pasync2025-05-05T23:09:02Z
dc.date.updated2025-02-21T08:32:38Z
dc.description.correctorkzs
dc.identifier.citationAmerican Journal Of Hematology. -100 : 1 (2024), p. 185-188. -Am. J. Hematol. - 0361-8609 1096-8652
dc.identifier.doihttp://dx.doi.org/10.1002/ajh.27515
dc.identifier.issn1096-8652
dc.identifier.issn0361-8609
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM128007
dc.identifier.scopus85208026406
dc.identifier.urihttps://hdl.handle.net/2437/387266
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1002/ajh.27515
dc.identifier.wos001358263600001
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleThe impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia
dc.typefolyóiratcikk
dc.typelevél
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_American J Hematol - 2024 - DiNardo - The impact of post‐remission granulocyte colony‐stimulating factor use in the phase 3.pdf
Méret:
952.62 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat